Renin-Angiotensin-System (RAS)-Acting Agents Global Market Report 2025

Renin-Angiotensin-System (RAS)-Acting Agents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on renin-angiotensin-system (ras)-acting agents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for renin-angiotensin-system (ras)-acting agents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The renin-angiotensin-system (ras)-acting agents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Drug Class: Angiotensin-Converting Enzyme (ACE) Inhibitors; Angiotensin II Receptor Blockers (ARBs); Renin Inhibitors; Aldosterone Antagonists; Other Drug Classes

2) By Indication: Hypertension; Heart Failure; Chronic Kidney Disease; Diabetic Nephropathy; Coronary Artery Disease

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Specialty Clinics

4) By End-User: Hospitals; Research Institutes; Pharmaceutical Companies; Other End-Users

Subsegments:

1) By Angiotensin-Converting Enzyme (ACE) Inhibitors: Captopril; Enalapril; Lisinopril; Ramipril; Perindopril

2) By Angiotensin II Receptor Blockers (ARBs): Losartan; Valsartan; Irbesartan; Olmesartan; Telmisartan

3) By Renin Inhibitors: Aliskiren

4) By Aldosterone Antagonists: Spironolactone; Eplerenone

5) By Other Drug Classes: Dual Angiotensin Receptor-Neprilysin Inhibitors (ARNIs); Endothelin Receptor Antagonists; Vasopeptidase Inhibitors; Mineralocorticoid Receptor Antagonists (MRAs); Angiotensin Receptor Blockers With Neprilysin Inhibitors (ARNBIs)

Companies Mentioned: Pfizer Inc.; Merck And Co. Inc.; Bayer AG; Sanofi S.A.; Bristol-Myers Squibb Company

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Renin-Angiotensin-System (RAS)-Acting Agents Market Characteristics
3. Renin-Angiotensin-System (RAS)-Acting Agents Market Trends And Strategies
4. Renin-Angiotensin-System (RAS)-Acting Agents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Renin-Angiotensin-System (RAS)-Acting Agents Growth Analysis And Strategic Analysis Framework
5.1. Global Renin-Angiotensin-System (RAS)-Acting Agents PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Renin-Angiotensin-System (RAS)-Acting Agents Market Growth Rate Analysis
5.4. Global Renin-Angiotensin-System (RAS)-Acting Agents Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Renin-Angiotensin-System (RAS)-Acting Agents Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Renin-Angiotensin-System (RAS)-Acting Agents Total Addressable Market (TAM)
6. Renin-Angiotensin-System (RAS)-Acting Agents Market Segmentation
6.1. Global Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Angiotensin-Converting Enzyme (ACE) Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Renin Inhibitors
Aldosterone Antagonists
Other Drug Classes
6.2. Global Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypertension
Heart Failure
Chronic Kidney Disease
Diabetic Nephropathy
Coronary Artery Disease
6.3. Global Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Specialty Clinics
6.4. Global Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Research Institutes
Pharmaceutical Companies
Other End-Users
6.5. Global Renin-Angiotensin-System (RAS)-Acting Agents Market, Sub-Segmentation Of Angiotensin-Converting Enzyme (ACE) Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Captopril
Enalapril
Lisinopril
Ramipril
Perindopril
6.6. Global Renin-Angiotensin-System (RAS)-Acting Agents Market, Sub-Segmentation Of Angiotensin II Receptor Blockers (ARBs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Losartan
Valsartan
Irbesartan
Olmesartan
Telmisartan
6.7. Global Renin-Angiotensin-System (RAS)-Acting Agents Market, Sub-Segmentation Of Renin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Aliskiren
6.8. Global Renin-Angiotensin-System (RAS)-Acting Agents Market, Sub-Segmentation Of Aldosterone Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Spironolactone
Eplerenone
6.9. Global Renin-Angiotensin-System (RAS)-Acting Agents Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dual Angiotensin Receptor-Neprilysin Inhibitors (ARNIs)
Endothelin Receptor Antagonists
Vasopeptidase Inhibitors
Mineralocorticoid Receptor Antagonists (MRAs)
Angiotensin Receptor Blockers With Neprilysin Inhibitors (ARNBIs)
7. Renin-Angiotensin-System (RAS)-Acting Agents Market Regional And Country Analysis
7.1. Global Renin-Angiotensin-System (RAS)-Acting Agents Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Renin-Angiotensin-System (RAS)-Acting Agents Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agents Market
8.1. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agents Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Renin-Angiotensin-System (RAS)-Acting Agents Market
9.1. China Renin-Angiotensin-System (RAS)-Acting Agents Market Overview
9.2. China Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Renin-Angiotensin-System (RAS)-Acting Agents Market
10.1. India Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Renin-Angiotensin-System (RAS)-Acting Agents Market
11.1. Japan Renin-Angiotensin-System (RAS)-Acting Agents Market Overview
11.2. Japan Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Renin-Angiotensin-System (RAS)-Acting Agents Market
12.1. Australia Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Renin-Angiotensin-System (RAS)-Acting Agents Market
13.1. Indonesia Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Renin-Angiotensin-System (RAS)-Acting Agents Market
14.1. South Korea Renin-Angiotensin-System (RAS)-Acting Agents Market Overview
14.2. South Korea Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Renin-Angiotensin-System (RAS)-Acting Agents Market
15.1. Western Europe Renin-Angiotensin-System (RAS)-Acting Agents Market Overview
15.2. Western Europe Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Renin-Angiotensin-System (RAS)-Acting Agents Market
16.1. UK Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Renin-Angiotensin-System (RAS)-Acting Agents Market
17.1. Germany Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Renin-Angiotensin-System (RAS)-Acting Agents Market
18.1. France Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Renin-Angiotensin-System (RAS)-Acting Agents Market
19.1. Italy Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Renin-Angiotensin-System (RAS)-Acting Agents Market
20.1. Spain Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Renin-Angiotensin-System (RAS)-Acting Agents Market
21.1. Eastern Europe Renin-Angiotensin-System (RAS)-Acting Agents Market Overview
21.2. Eastern Europe Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Renin-Angiotensin-System (RAS)-Acting Agents Market
22.1. Russia Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Renin-Angiotensin-System (RAS)-Acting Agents Market
23.1. North America Renin-Angiotensin-System (RAS)-Acting Agents Market Overview
23.2. North America Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Renin-Angiotensin-System (RAS)-Acting Agents Market
24.1. USA Renin-Angiotensin-System (RAS)-Acting Agents Market Overview
24.2. USA Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Renin-Angiotensin-System (RAS)-Acting Agents Market
25.1. Canada Renin-Angiotensin-System (RAS)-Acting Agents Market Overview
25.2. Canada Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Renin-Angiotensin-System (RAS)-Acting Agents Market
26.1. South America Renin-Angiotensin-System (RAS)-Acting Agents Market Overview
26.2. South America Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Renin-Angiotensin-System (RAS)-Acting Agents Market
27.1. Brazil Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Renin-Angiotensin-System (RAS)-Acting Agents Market
28.1. Middle East Renin-Angiotensin-System (RAS)-Acting Agents Market Overview
28.2. Middle East Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Renin-Angiotensin-System (RAS)-Acting Agents Market
29.1. Africa Renin-Angiotensin-System (RAS)-Acting Agents Market Overview
29.2. Africa Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Renin-Angiotensin-System (RAS)-Acting Agents Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Renin-Angiotensin-System (RAS)-Acting Agents Market Competitive Landscape And Company Profiles
30.1. Renin-Angiotensin-System (RAS)-Acting Agents Market Competitive Landscape
30.2. Renin-Angiotensin-System (RAS)-Acting Agents Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
31. Renin-Angiotensin-System (RAS)-Acting Agents Market Other Major And Innovative Companies
31.1. AstraZeneca plc
31.2. Novartis AG
31.3. GSK plc
31.4. Teva Pharmaceutical Industries Ltd.
31.5. Boehringer Ingelheim GmbH
31.6. Sandoz International GmbH
31.7. Astellas Pharma Inc.
31.8. Bausch Health Companies Inc.
31.9. Aurobindo Pharma Limited
31.10. Cipla Limited
31.11. Dr. Reddy's Laboratories Ltd.
31.12. Biocon Limited
31.13. Daiichi Sankyo Company Limited
31.14. Glenmark Pharmaceuticals Ltd.
31.15. Torrent Pharmaceuticals Ltd.
32. Global Renin-Angiotensin-System (RAS)-Acting Agents Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Renin-Angiotensin-System (RAS)-Acting Agents Market
34. Recent Developments In The Renin-Angiotensin-System (RAS)-Acting Agents Market
35. Renin-Angiotensin-System (RAS)-Acting Agents Market High Potential Countries, Segments and Strategies
35.1 Renin-Angiotensin-System (RAS)-Acting Agents Market In 2029 - Countries Offering Most New Opportunities
35.2 Renin-Angiotensin-System (RAS)-Acting Agents Market In 2029 - Segments Offering Most New Opportunities
35.3 Renin-Angiotensin-System (RAS)-Acting Agents Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings